A framework for personalized medicine: prediction of drug sensitivity in cancer by proteomic profiling

Abstract

The goal of personalized medicine is to provide patients optimal drug screening and treatment based on individual genomic or proteomic profiles. Reverse-Phase Protein Array (RPPA) technology offers proteomic information of cancer patients which may be directly related to drug sensitivity. For cancer patients with different drug sensitivity, the proteomic… (More)
DOI: 10.1186/1477-5956-10-S1-S13

Topics

Cite this paper

@inproceedings{Kim2012AFF, title={A framework for personalized medicine: prediction of drug sensitivity in cancer by proteomic profiling}, author={Dong-Chul Kim and Xiaoyu Wang and Chin-Rang Yang and Jean Gao}, booktitle={Proteome Science}, year={2012} }